106 related articles for article (PubMed ID: 37141129)
1. [Mental disorders associated with acute COVID-19: clinical picture, therapy approaches].
Samushiya MA; Chorbinskaya SA; Kolpakov EA; Shmyrev VI; Kryzhanovskiy SM; Baranovskaya OP; Trifonova EV; Devyatkin AV; Kydryavtseva NA; Maeva VO; Schepkina EV
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(4. Vyp. 2):52-59. PubMed ID: 37141129
[TBL] [Abstract][Full Text] [Related]
2. [An impact of the COVID-19 pandemia on the onset and course of mental disorders in elderly].
Yakovleva OB; Safarova TP; Tsvetaeva DA
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(5):131-138. PubMed ID: 37315252
[TBL] [Abstract][Full Text] [Related]
3. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
4. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
Cerbo AD
Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
[TBL] [Abstract][Full Text] [Related]
8. [Structure and dynamics of depressive disorders in patients with a new coronavirus infection].
Osipova NN; At'kova EO; Akimova DD; Dmitrieva EV; Bardenshtein LM
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11. Vyp. 2):96-100. PubMed ID: 38127708
[TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
13. Proactive anti-inflammatory therapy in the advanced stages of a new coronavirus infection. Main results of the inpatient phase of the COLORIT study (Colchicin vs. Ruxolitinib and secukinumab in an open, prospective, randomized trial in patients with novel coronavirus infection COVID-19).
Mareev VY; Orlova YA; Plisuk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malahov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov МA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina EM; Sinitsyn VE; Mareev YV; Shatokhina EA; Begrambekova YL; Kamalov AA
Kardiologiia; 2022 Dec; 62(12):11-22. PubMed ID: 36636972
[TBL] [Abstract][Full Text] [Related]
14. NEUROPROTECTIVE AND ANTIOXIDANT POTENTIAL OF MONTELUKAST-ACETYLCYSTEINE COMBINATION THERAPY FOR BRAIN PROTECTION IN PATIENTS WITH COVID-19 INDUCED PNEUMONIA.
Samsonia M; Kandelaki M; Baratashvili N; Gvaramia L
Georgian Med News; 2023 Feb; (335):111-118. PubMed ID: 37042600
[TBL] [Abstract][Full Text] [Related]
15. Delirium and Inflammation in Older Adults Hospitalized for COVID-19: A Cohort Study.
Forget MF; Del Degan S; Leblanc J; Tannous R; Desjardins M; Durand M; Vu TTM; Nguyen QD; Desmarais P
Clin Interv Aging; 2021; 16():1223-1230. PubMed ID: 34234422
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic medication use in children and adolescents in an inpatient setting.
Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
[TBL] [Abstract][Full Text] [Related]
17. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
[TBL] [Abstract][Full Text] [Related]
18. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and safety of Melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Ziaei A; Davoodian P; Dadvand H; Safa O; Hassanipour S; Omidi M; Masjedi M; Mahmoudikia F; Rafiee B; Fathalipour M
Trials; 2020 Oct; 21(1):882. PubMed ID: 33106171
[TBL] [Abstract][Full Text] [Related]
20. Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.
Nemani K; Williams SZ; Olfson M; Leckman-Westin E; Finnerty M; Kammer J; Smith TE; Silverman DJ; Lindenmayer JP; Capichioni G; Clelland J; Goff DC
JAMA Netw Open; 2022 May; 5(5):e2210743. PubMed ID: 35522282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
